Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JMS CoTSE:7702 +1.32%62 Altman Z-Score is 1.52 as of Jul. 30, 2026, which is 14% below its 10-year median of 1.76. GuruFocus rates TSE:7702 with a GF Score™ of 62/100 and a GF Value™ of 円469.13 (Fairly Valued). The stock has 10 warning signs investors should review. Among 805 Medical Devices & Instruments companies, JMS Co ranks worse than 68.57% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Warning Sign:
Altman Z-score of 1.52 is in distress zone. This implies bankruptcy possibility in the next two years.
JMS Co has a Altman Z-Score of 1.52, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for JMS Co's Altman Z-Score or its related term are showing as below:
TSE:7702'
s Altman Z-Score Range Over the Past 10 Years
Min: 1.51 Med: 1.76 Max: 2
Current: 1.52
During the past 13 years, JMS Co's highest Altman Z-Score was 2.00. The lowest was 1.51. And the median was 1.76.
JMS Co (TSE:7702) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
JMS Co Altman Z-Score Related Terms
JMS Co Altman Z-Score Historical Data
* Premium members only.
The historical data trend for JMS Co's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7702 vs ISRG, BDX, MDLN: Altman Z-Score Comparison
For the Medical Instruments & Supplies subindustry, JMS Co's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JMS Co Altman Z-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JMS Co's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where JMS Co's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
JMS Co's Altman Z-Score for today is calculated with this formula:
Z
=
1.2
*
X1
+
1.4
*
X2
+
3.3
*
X3
+
0.6
*
X4
+
1.0
*
X5
=
1.2
*
0.2492
+
1.4
*
0.1868
+
3.3
*
0.0005
+
0.6
*
0.2692
+
1.0
*
0.7927
=
1.52
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
JMS Co (TSE:7702) has a Altman Z-Score of 1.52 as of Jul. 30, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on JMS Co and its competitors. This is 14% below median its historical median of 1.76. Over the past decade, JMS Co's Altman Z-Score has ranged from 1.51 to 2.00. According to the industry distribution chart, JMS Co ranks #552 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 68.6%.
Is JMS Co's Altman Z-Score too high?
JMS Co's current Altman Z-Score of 1.52 is 14% below median its 10-year median of 1.76. Over the past 10 years, this metric has ranged from a low of 1.51 to a high of 2.00. The Medical Devices & Instruments industry median Altman Z-Score is 2.99. JMS Co's value of 1.52 is 49.2% below this industry median. Based on the distribution chart, JMS Co ranks #552 out of 805 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, JMS Co has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does JMS Co's Altman Z-Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JMS Co ranks #552 out of 805 companies for Altman Z-Score. This places JMS Co in the lower half of its industry. The industry median Altman Z-Score is 2.99. JMS Co's value of 1.52 is 49.2% below this benchmark. Historically, JMS Co's own Altman Z-Score has ranged from 1.51 to 2.00 over the past decade. While the company's 10-year median is 1.76 vs. the industry median of 2.99, JMS Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Medical Devices & Instruments company?
The median Altman Z-Score among Medical Devices & Instruments companies is 2.99, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JMS Co's current Altman Z-Score of 1.52 is 49.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on JMS Co and its competitors. For the Medical Devices & Instruments industry, the median Altman Z-Score is 2.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JMS Co's current Altman Z-Score is 1.52, which is 14% below median its own 10-year median of 1.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMS Co stock overvalued right now?
Based on GuruFocus' analysis, JMS Co (TSE:7702) is currently considered Fairly Valued. The stock's GF Value™ is 円469.13, compared to a current price of 円459.00 — trading 2.2% below its estimated fair value. The current Altman Z-Score is 1.52, which is 14% below median its 10-year median of 1.76 and 49.2% below the Medical Devices & Instruments industry median of 2.99. JMS Co's overall GF Score™ is 62/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For JMS Co (TSE:7702), the current Altman Z-Score is 1.52 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JMS Co (TSE:7702) Overvalued in 2026?
Based on GuruFocus' analysis, JMS Co stock appears to be undervalued.
The current stock price of 円459.00 is trading 2.2% below its estimated GF Value™ of 円469.13.
GuruFocus considers JMS Co to be Fairly Valued.
Key valuation signals for TSE:7702:
Altman Z-Score: 1.52 (14% below median its 10-year median of 1.76)
GF Value™: 円469.13 vs. price of 円459.00 (2.2% below fair value)
Industry Position: 49.2% below the Medical Devices & Instruments median (#552 of 805)
No single metric tells the full story. See the TSE:7702 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JMS Co Ltd is a Japan-based medical equipment manufacturer. The company is engaged in the manufacture, sale, export, and import of medical equipment and pharmaceuticals. Products offered by the company include an infusion pump, syringe pump, surgical gown, peritoneal dialysate, dialyzer, mask cap, sheet for treatment, pacemaker, heat exchanger, blood bag, among others. JMS has network operations in various countries including Europe, North America, Asia, the Middle East, Latin America and Africa.
62GF Score
Get the complete analysis for TSE:7702
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7702 has been successfully added to your 
